Microbiology and Immunology · 1989 · 20 citations · 7 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial AgentsAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial InfectionsAntibacterial Susceptibility TestingAntibiotic Susceptibility TestingMolecular Drug Susceptibility TestingMycobacterial DiagnosisMycobacterial DiseasePhenotypic Characterization Of IsolatesPhenotypic Drug Susceptibility TestingPhenotypic Susceptibility Profiling
Mycobacterium avium and M. intracellulare of human and natural sources, identified by the Gen-Probe Rapid Diagnostic System for M. avium Complex (MAC) were studied for susceptibility to eight different drugs. In the case of human isolates of MAC, the following was noted. M. avium showed nearly the same susceptibility to streptomycin, kanamycin, ethambutol, and clofazimine as was seen with M. intracellulare. M. avium was much more resistant to rifampicin and rifabutin than was M. intracellulare, and M. avium was more susceptible to quinolones such as ofloxacin and ciprofloxacin. Conversely, in the case of MAC from natural sources, there was no difference between the susceptibility of M. avium and M. intracellulare to these antibacterial agents.
7
Treatment of Disease Due to Mycobacterium intracellulare
P T Davidson, Vinod Khanijo, Marian Goble et al. · Clinical Infectious Diseases · 1981 · 121 citations
Disease Due to Mycobacterium avium-intracellulare
Michael D. Iseman, Raymond F. Corpe, Richard O’Brien et al. · CHEST Journal · 1985 · 108 citations